We are live on ! Find out more
GCA

Greenwood Capital Associates Portfolio holdings

AUM $1.02B
1-Year Est. Return 28.26%
This Fund
S&P 500
This Quarter Est. Return
+4.49%
1 Year Est. Return
+28.26%
3 Year Est. Return
+81.29%
5 Year Est. Return
+95.78%
10 Year Est. Return
+421.94%
AUM
$397M
AUM Growth
+$8.31M
Cap. Flow
-$5.3M
Cap. Flow %
-1.33%
Top 10 Hldgs %
26.94%
Holding
208
New
42
Increased
62
Reduced
62
Closed
37

Sector Composition

Rank Sector Weight
1 Healthcare 12.49%
2 Communication Services 10.26%
3 Technology 9.58%
4 Consumer Discretionary 8.95%
5 Industrials 8.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMQQ icon
26
EMQQ The Emerging Markets Internet & Ecommerce ETF
EMQQ
$272M
$5.32M 1.34%
165,763
+42,635
+35% +$1.38M
IGSB icon
27
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.3B
$5.31M 1.34%
99,349
-1,142
-1% -$60.4K
NEE icon
28
NextEra Energy
NEE
$179B
$5.27M 1.33%
102,932
-920
-0.9% -$45.3K
SBUX icon
29
Starbucks
SBUX
$121B
$5.02M 1.26%
59,848
-535
-0.9% -$42K
RING icon
30
iShares MSCI Global Gold Miners ETF
RING
$2.49B
$4.88M 1.23%
+238,945
New +$4.15M
INTC icon
31
Intel
INTC
$513B
$4.86M 1.22%
101,501
-43,173
-30% -$2.14M
CCI icon
32
Crown Castle
CCI
$31.5B
$4.74M 1.19%
36,336
+13,301
+58% +$1.71M
ZTS icon
33
Zoetis
ZTS
$29.9B
$4.71M 1.18%
41,453
-4,557
-10% -$477K
EMR icon
34
Emerson Electric
EMR
$91.3B
$4.67M 1.17%
69,961
-602
-0.9% -$40.3K
KO icon
35
Coca-Cola
KO
$372B
$4.62M 1.16%
90,771
-422
-0.5% -$20.7K
NVO
36
Novo Nordisk
NVO
$202B
$4.39M 1.1%
+171,890
New +$4.25M
PFF icon
37
iShares Preferred and Income Securities ETF
PFF
$13.2B
$4.26M 1.07%
115,605
+1,305
+1% +$47.8K
GILD icon
38
Gilead Sciences
GILD
$169B
$4.25M 1.07%
+62,865
New +$4.14M
PXD
39
DELISTED
Pioneer Natural Resource Co.
PXD
$4.18M 1.05%
+27,167
New +$4.17M
EWG icon
40
iShares MSCI Germany ETF
EWG
$1.68B
$3.67M 0.92%
+130,935
New +$3.66M
SPHB icon
41
Invesco S&P 500 High Beta ETF
SPHB
$944M
$3.57M 0.9%
+83,450
New +$3.52M
SPHQ icon
42
Invesco S&P 500 Quality ETF
SPHQ
$19.9B
$3.56M 0.9%
107,503
+45,693
+74% +$1.49M
ILF icon
43
iShares Latin America 40 ETF
ILF
$3.73B
$3.52M 0.88%
+104,220
New +$3.44M
UNP icon
44
Union Pacific
UNP
$174B
$3.38M 0.85%
19,996
-17,581
-47% -$3.01M
COP icon
45
ConocoPhillips
COP
$151B
$3.24M 0.82%
53,148
-13,291
-20% -$827K
EMLC icon
46
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.79B
$3.19M 0.8%
91,769
+267
+0.3% +$8.92K
CB icon
47
Chubb
CB
$134B
$3.15M 0.79%
21,366
+142
+0.7% +$20.5K
IJR icon
48
iShares Core S&P Small-Cap ETF
IJR
$112B
$3.08M 0.78%
+39,340
New +$3.05M
ABBV icon
49
AbbVie
ABBV
$441B
$3.06M 0.77%
+42,005
New +$3.3M
NEAR icon
50
iShares Short Maturity Bond ETF
NEAR
$4.88B
$2.96M 0.74%
+58,755
New +$2.95M

Similar funds

Greenwood Capital Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Greenwood Capital Associates held 208 positions worth $397M, up 2.1% from $389M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Greenwood Capital Associates's Q2 2019 filing shows 42 new, 62 increased, 62 reduced and 37 closed positions. Its largest new stake was Merck: 71,722 shares worth $5.74M. The largest sale was Bristol-Myers Squibb, an estimated $6.96M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 13% a quarter earlier, followed by Communication Services and Technology.

  • Greenwood Capital Associates's largest Q2 2019 buy was Merck: 71,722 shares worth $5.74M.
  • Greenwood Capital Associates added most to Electronic Arts in Q2 2019, an estimated $3.23M increase.
  • Greenwood Capital Associates's biggest Q2 2019 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $6.06M.
  • Greenwood Capital Associates fully exited Bristol-Myers Squibb in Q2 2019, selling an estimated $6.96M.
  • Greenwood Capital Associates's ten largest holdings make up 27% of its $397M portfolio in Q2 2019.
  • Greenwood Capital Associates opened 42 new positions and closed 37 in Q2 2019.
  • Greenwood Capital Associates's portfolio value rose 2.1% quarter-over-quarter to $397M.

Based on Greenwood Capital Associates's 13F filing for Q2 2019, filed 13 Aug 2019.